461 related articles for article (PubMed ID: 30299265)
1. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review.
Günalan E; Yaba A; Yılmaz B
J Turk Ger Gynecol Assoc; 2018 Nov; 19(4):220-232. PubMed ID: 30299265
[TBL] [Abstract][Full Text] [Related]
2. Effect of Nutritional Supplementation on Oxidative Stress and Hormonal and Lipid Profiles in PCOS-Affected Females.
Dubey P; Reddy S; Boyd S; Bracamontes C; Sanchez S; Chattopadhyay M; Dwivedi A
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578816
[TBL] [Abstract][Full Text] [Related]
3. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome.
Alesi S; Ee C; Moran LJ; Rao V; Mousa A
Adv Nutr; 2022 Aug; 13(4):1243-1266. PubMed ID: 34970669
[TBL] [Abstract][Full Text] [Related]
4. Nutritional and dietary aspects in polycystic ovary syndrome: insights into the biology of nutritional interventions.
Neves LPP; Marcondes RR; Maffazioli GN; Simões RS; Maciel GAR; Soares JM; Baracat EC
Gynecol Endocrinol; 2020 Dec; 36(12):1047-1050. PubMed ID: 32960105
[TBL] [Abstract][Full Text] [Related]
5. Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.
Rondanelli M; Perna S; Faliva M; Monteferrario F; Repaci E; Allieri F
Arch Gynecol Obstet; 2014 Dec; 290(6):1079-92. PubMed ID: 25200687
[TBL] [Abstract][Full Text] [Related]
6. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
Elkind-Hirsch KE
Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
[TBL] [Abstract][Full Text] [Related]
8. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity.
Cowan S; Lim S; Alycia C; Pirotta S; Thomson R; Gibson-Helm M; Blackmore R; Naderpoor N; Bennett C; Ee C; Rao V; Mousa A; Alesi S; Moran L
BMC Endocr Disord; 2023 Jan; 23(1):14. PubMed ID: 36647089
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome and obesity: clinical aspects and nutritional management.
Frias-Toral E; Garcia-Velasquez E; de Los Angeles Carignano M; Rodriguez-Veintimilla D; Alvarado-Aguilera I; Bautista-Litardo N
Minerva Endocrinol (Torino); 2022 Jun; 47(2):215-241. PubMed ID: 33792235
[TBL] [Abstract][Full Text] [Related]
11. Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis.
He C; Lin Z; Robb SW; Ezeamama AE
Nutrients; 2015 Jun; 7(6):4555-77. PubMed ID: 26061015
[TBL] [Abstract][Full Text] [Related]
12. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
Advani K; Batra M; Tajpuriya S; Gupta R; Saraswat A; Nagar HD; Makwana L; Kshirsagar S; Kaul P; Ghosh AK; Pradhan S; Mehta A; Jaiswal A; Nakhate KT; Kamdi S
J Obstet Gynaecol; 2020 Jan; 40(1):96-101. PubMed ID: 31339394
[TBL] [Abstract][Full Text] [Related]
14. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
González F
Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
[TBL] [Abstract][Full Text] [Related]
15. Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome.
Banaszewska B; Pawelczyk L; Spaczynski R
Reprod Biol; 2019 Dec; 19(4):309-315. PubMed ID: 31606349
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome and mitochondrial dysfunction.
Zhang J; Bao Y; Zhou X; Zheng L
Reprod Biol Endocrinol; 2019 Aug; 17(1):67. PubMed ID: 31420039
[TBL] [Abstract][Full Text] [Related]
17. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
[TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo LG; Patchava S; Laing I
Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
[TBL] [Abstract][Full Text] [Related]
19. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
20. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
Arentz S; Abbott JA; Smith CA; Bensoussan A
BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
